Nutrition Support Challenges in Hematopoietic Stem Cell Transplant Patients

Abstract

Hematopoietic stem cell transplant (HSCT) patients can present a number of nutrition challenges despite recent advancements in medical care. Several areas of controversy exist, including whether probiotics can be safely used; the use of probiotics continues to expand but efficacy and safety is a concern in immunocompromised patients, including HSCT recipients. Second, parenteral nutrition continues to be the primary avenue for nutrition support despite growing evidence that enteral feedings can be successfully administered. Last, tight glycemic control has been associated with positive clinical outcomes in hospitalized patients. However, whether tight glycemic control can be achieved and is of benefit in this patient population continues to be debated. This article will discuss the current challenges facing clinicians regarding these 3 issues—probiotics, enteral nutrition support, and glycemic control—and future directions in HSCT.

Get full access to this article

View all access options for this article.

References

Floch MH, Montrose DC. Use of probiotics in humans: an analysis of the literature. Gastroenterol Clin North Am.2005 ;34:547 -570.

Stedmans's Medical Dictionary. http://www.stedmans.com/section.cfm/45. Accessed July 28, 2008.

Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev. 2003;(4):CD003048 . doi:10.1002/14651858.CD003048.pub2 .

Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics.2005 ;115:178 -181.

Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clin Infect Dis. 2003;36:775 -780.

Morrison V, Haake R, Weisdorf D. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore).1993 ;72:78 -89.

Cairoli R, Marenco P, Perego R, de Cataldo F. Saccharomyces cerevisiae: fungemia with granulomas in the bone marrow in a patient undergoing BMT. Bone Marrow Transplant.1995 ;15:785 -786.

Kalima P, Masterton RG, Roddie PH, Thomas AE. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect. 1996;32:165 -167.

Riquelme AJ, Calvo MA, Guzman AM, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol.2003 ;36:41 -43.

10.

De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis. 2005;24:278 -280.

11.

Schlegel L, Lemerle S, Geslin P. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis.1998 ;17:887 -888.

12.

Arpi M, Vancanneyt M, Swings J, Leisner J. Six cases of Lactobacillus bacteraemia: identification of organisms and antibiotic susceptibility and therapy. Scand J Infect Dis.2003 ;35:404 -408.

13.

Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis.2004 ;38:62 -69.

14.

Anaisse E, Bodey G, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis.1989 ;11:369 -378.

15.

Manzella JP, Shaffer S, Agarwal N, Kellogg JA. Saccharomyces cerevisiae fungemia in a multiply traumatized patient. J Trauma. 1989;29:129 -130.

16.

Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis.1990 ;12:406 -411.

17.

Nielsen H, Stenderup J, Bruun B. Fungemia with Saccharomycetaceae. Scand J Infect Dis.1990 ;22:581 -584.

18.

Zunic P, Lacotte J, Pegoix M, et al. Saccharomyces boulardii. Apropos of a case. Therapie.1991 ;46;497 -501.

19.

Oriol A, Ribera JM, Arnal J, Milla F, Batlle M, Feliu E. Saccharomyces cerevisiae septicemia in a patient with myelodys-plastic syndrome. Am J Hematol.1993 ;43:325 -326.

20.

Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1→ 3)-β-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol. 1997;35:371 -374.

21.

Bassetti S, Frei R, Zimmerli W. Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii [abstract]. Paper presented at: 10th International Symposium on Infections in the Immunocompromised Host, Davos, Switzerland;1998 .

22.

Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer.2000 ;8:504 -505.

23.

Hennequin C, Kauffmann-Lacroix C, Jobert A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis.2000 ;19:16 -20.

24.

Lherm T, Monet C, Nougiere B, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med.2002 ;28:797 -801.

25.

Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40:1625 -1634.

26.

Graf C, Gavazzi G. Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. J Infect.2007 ;54:310 -311.

27.

Majcher-Peszynska J, Heine W, Richter I, Eggers G, Mohr C. Persistent Lactobacillus casei subspecies rhamnosus bacteremia in a 14 year old girl with acute myeloid leukemia. A case report. Klin Pediatr.1999 ;211:53 -56.

28.

Sullivan A, Nord CE. Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis.2006 ;38:327 -331.

29.

Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr.2001 ;73(suppl):465S -470S.

30.

Fredenucci I, Chomarat M, Boucaud C, Flandrois JP. Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin Infect Dis.1998 ;27:222 -223.

31.

Niault M, Thomas J, Prost F, Ansari FH, Kalfon P. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis.1999 ;28:930 .

32.

Viggiano M, Badetti C, Bernini V, Garabedian M, Manelli JC. Saccharomyces boulardii fungemia in a patient with severe burns. Ann Fr Anesth Reanim.1995 ;14:356 -358.

33.

Pletinex M, Legein J, Vandenplas Y. Fungemia with Saccharomyces boulardii in a 1 year old girl with pretreated diarrhea. J Pediatr Gastroenterol Nutr.1995 ;21:113 -115.

34.

Rijnders BJA, Van Wijngaerden E, Verwaest C, Peetermans WE. Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Med. 2000;26:825 .

35.

Perapoch J, Planes AM, Querol A, et al. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis. 2000;19:468 -470.

36.

Fiore NF, Conway JH, West KW, Kleiman MB. Saccharomyces cerevisiae infections in children. Pediatr Infect Dis. 1998;7:1177 -1179.

37.

Eddy JT, Stamatakis MK, Makela EH. Saccharomyces boulardii fungemia for the treatment of Clostridium difficile associated colitis. Ann Pharmacother.1997 ;31:919 -921.

38.

Sethi N, Mandell W. Saccharomyces fungemia in a patient with AIDS. N Y State J Med.1988 ;88:278 -279.

39.

Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis. 1987;8:113 -117.

40.

Sheppard DC, Rene P, Harris AD, et al. Simple strategy for direct identification of medically important yeast species from positive blood culture vials. J Clin Microbiol.1999 ;37:2040 -2041.

41.

Piarroux R, Millon L, Bardonnet K, Vagner O, Koenig H. Are live Saccharomyces yeasts harmful to patients? Lancet. 1999;353:1851 -1852.

42.

Eng RH, Drehmel R, Smith SM, Goldstein EJ. Saccharomyces cerevisiae infections in man. Sabouraudia.1984 ;22:403 -407.

43.

Tawfik OW, Papasian CJ, Dixon AY, Potter LM. Saccharomyces cerevisiae pneumonia in a patient with AIDS. J Clin Microbiol. 1989;27:1689 -1691.

44.

Marian M, McGinnis C. Overview of enteral nutrition. In: Gottschlich M, ed. The ASPEN Nutrition Support Core Curriculum: A Case-based Approach—The Adult Patient. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2007:187 -208.

45.

Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant.2001 ;27(suppl 2):S3 -S11.

46.

Murray SM, Pindoria S. Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev.2002 (2): CD002920. doi:10.1002/14651858.CD002920 .

47.

Lenssen P, Bruemmer B, Aker SN, McDonald GB. Nutrient support in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2001;25:219 -228.

48.

Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res.1987 ;47:3309 -3316.

49.

Mulder PO, Bouman JG, Gietema JA, et al. Hyperalimentation in autologous bone marrow transplantation for solid tumors. Cancer. 1989;64:2045 -2052.

50.

Papadopoulou A, MacDonald A, Williams MD, Darbyshire PJ, Booth IW. Enteral nutrition after bone marrow transplantation. Arch Dis Child. 1997;77:131 -136.

51.

Roberts SR, Miller JE. Success using PEG tubes in marrow transplant recipients. Nutr Clin Pract.1998 ;13:74 -78.

52.

Pietsch JB, Ford C, Whitlock JA. Nasogastric tube feedings in children with high-risk cancer: a pilot study. J Pediatr Hematol Oncol. 1999;21:111 -114.

53.

Pedersen AM, Kok K, Petersen G, Nielson OH, Michaelson KF, Schmiegelow K. Percutaneous endoscopic gastrostomy in children with cancer. Acta Paediatr.1999 ;88:849 -852.

54.

Barron MA, Duncan DS, Green GJ, et al. Efficacy and safety of radiologically placed gastrostomy tubes in paediatric haematology/oncology patients. Med Pediatr Oncol.2000 ;34:177 -182.

55.

Sefcick A, Anderton D, Byrne JL, Teahon K, Russell NH. Naso-jejunal feeding in allogeneic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant.2001 ;28:1135 -1139.

56.

Langdana A, Tully N, Molloy E, Bourke B, O'Meara A. Intensive enteral nutrition support in paediatric bone marrow transplantation. Bone Marrow Transplant.2001 ;27:741 -746.

57.

Hopman GD, Pena EG, Le Cessie S, Van Weel MH, Vossen JM, Mearin ML. Tube feeding and bone marrow transplantation. Med Pediatric Oncol. 2003;40:375 -379.

58.

Hastings Y, White M, Young J. Enteral nutrition and bone marrow transplantation. J Pediatr Oncol Nurs.2006 ;23:103 -110.

59.

Seguy D, Berthon C, Micol JB, et al. Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloblative conditioning. Transplantation.2006 ;82:835 -839.

60.

Mattsson J, Westin S, Edlund S, Remberger M. Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease. Bone Marrow Transplant. 2006;38:629 -633.

61.

Svahn BM, Remberger M, Myrback KE, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood.2002 ;100:4317 -4324.

62.

Svahn BM, Ringden O, Remberger M. Long-term follow-up of patients treated at home during the panctyopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant.2005 ;36:511 -516.

63.

Lenssen P. Hematopoietic stem cell transplantation. In: Rolandelli R, Bankhead R, Boullata J, Compher C, eds. Clinical Nutrition: Enteral and Tube Feeding. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005: 544-558.

64.

Lipkin AC, Lenssen P, Dickson BJ. Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract. 2005;20:423 -439.

65.

Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation.1987 ;43:833 -838.

66.

van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New Engl J Med.2001 ;345:1359 -1367.

67.

Nasraway SA. Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr.2006 ;30:254 -258.

68.

Furnary AP, Gao G, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007 -1018.

69.

Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA.2003 ;31:634 -635.

70.

van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med.2003 ;31:359 -366.

71.

Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc.2003 ;78:1471 -1478.

72.

Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992 -1000.

73.

Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation.2004 ;109:1497 -1502.

74.

Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005;80:1558 -1567.

75.

Cheung NW, Zaccaria C, Napier B, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care.2005 ;28:2367 -2371.

76.

van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. New Engl J Med.2006 ;354:449 -461.

77.

Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest.2006 ;129:644 -650.

78.

Fuji S, Kim SW, Mori S, et al. Hyperglycemia during neutropenia was associated with the risk of infection and organ dysfunction in patients undergoing allogeneic hematopoietic stem cell transplantation [abstract]. Blood. 2006;108 . Abstract 5308.

79.

Garg R, Bhutani H, Alyea E, Pendergrass M. Hyperglycemia and length of hospital stay in patients hospitalized for bone marrow transplantation. Diabetes Care.2007 ;30:993 -994.

80.

Sheean PM, Braunschweig C, Rich E. The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: a pilot study. J Am Diet Assoc.2004 ;104:1352 -1360.

81.

Sheean PM, Braunschweig C. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition exposure in hematopoietic stem cell transplant recipients. JPEN J Parenter Enteral Nutr. 2006;30:345 -350.

82.

Sheean PM, Freels SA, Helton WS, Braunschweig C. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006;12:656 -664.

83.

Lenssen P. Total parenteral nutrition-induced hyperglycemia in heamtopoietic stem cell transplantation. J Am Diet Assoc. 2004;104:1349 -1351.

84.

Lestra JA, Fibbe WE, Zwinderman AH, Romijn JA, Kromhout D. Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant. 1999;23:933 -939.

85.

Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract.2004 ;10:77 -82.

86.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care.2005 ;28(suppl 1):S4 -S36.

87.

McCowen KC, Friel C, Sternberg J, et al. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications—a randomized clinical trial. Crit Care Med. 2000;28:3606 -3611.

88.

Inzucchi SE. Management of hyperglycemia in the hospital setting. New Engl J Med.2006 ;355:1903 -1911.